temoporfin has been researched along with Breast Cancer in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirohara, S; Ito, H; Kakiuchi, K; Kawai, T; Kawaichi, M; Matsui, H; Obata, M; Oka, C; Tamura, M; Tanihara, M; Totani, M; Yuasa, J | 1 |
| Chandran, P; Gupta, N; Koyakutty, M; Malarvizhi, GL; Nair, S; Ramachandran, R; Retnakumari, AP | 1 |
| Bezdetnaya, L; D'Hallewin, MA; Dumas, D; Gräfe, S; Guillemin, F; Kochetkov, D; Leroux, A; Viry-Babel, Y; Werkmeister, E; Zorin, V | 1 |
| Rogers, GS | 1 |
| Aubert, S; Bolotine, L; Burgos, P; Carré, MC; Even, P; Frochot, C; Guillemin, F; Merlin, JL; Teiten, MH; Viriot, ML | 1 |
| Baas, P; Haller, U; Klein, SD; Walt, H; Zimmermann, A | 1 |
| Cunderlíková, B; Friberg, EG; Moan, J; Pettersen, EO | 1 |
| Bezdetnaya, L; D'Hallewin, MA; Guillemin, F; Marchal, S; Teiten, MH | 1 |
| Bezdetnaya, L; Dumas, D; François, A; Guillemin, F; Marchal, S | 1 |
| Burkard, W; Dobler-Girdziunaite, D; Haller, U; Larsson, B; Walt, H | 1 |
| Haller, U; Koechli, OR; Schaer, GN; Schenk, V; Walt, H | 1 |
| Crompton, NE; Haller, U; Hornung, R; Jentsch, B; Walt, H | 1 |
| Crompton, NE; Haller, U; Hornung, R; Jentsch, B; Keefe, KA; Köchli, OR; Perewusnyk, G; Walt, H | 1 |
| Cattaneo, R; Haller, U; Jentsch, B; Koechli, OR; Schlosser, V; Walt, H | 1 |
| Degen, A; Dobler-Girdziunaite, D; Fehr, M; Hornung, R; Schwarz, V; Walt, H; Wyss, P | 1 |
| Bezdetnaya, L; Bour-Dill, C; Dicato, M; Guillemin, F; Merlin, JL; Pauly, ME; Teiten, MH | 1 |
1 trial(s) available for temoporfin and Breast Cancer
| Article | Year |
|---|---|
Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Porphyrins; Treatment Outcome | 2001 |
15 other study(ies) available for temoporfin and Breast Cancer
| Article | Year |
|---|---|
Synthesis, Photophysical Properties, and Biological Evaluation of trans-Bisthioglycosylated Tetrakis(fluorophenyl)chlorin for Photodynamic Therapy.
Topics: Animals; Breast; Breast Neoplasms; Cell Line, Tumor; Female; Halogenation; Humans; Hydrocarbons, Chlorinated; Mice; Mice, Inbred BALB C; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2015 |
A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing.
Topics: Breast; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Dasatinib; Drug Carriers; Female; Humans; Lactic Acid; Mesoporphyrins; Molecular Docking Simulation; Nanomedicine; Neoplasm Metastasis; Photochemotherapy; Photosensitizing Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein-Tyrosine Kinases; Pyrimidines; Serum Albumin; Thiazoles | 2014 |
Photodynamic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Injections, Intralesional; Mesoporphyrins; Mice; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents | 2008 |
Continuous low-irradiance photodynamic therapy: a new therapeutic paradigm.
Topics: Aminolevulinic Acid; Animals; Breast Neoplasms; Dihematoporphyrin Ether; Dose-Response Relationship, Radiation; Female; Humans; Light; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents | 2012 |
Specific fluorescent tracers. Imaging and applications for photodynamic therapy.
Topics: Biological Transport; Breast Neoplasms; Cell Survival; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Fluorescent Dyes; Glycosylation; Humans; Lysosomes; Mesoporphyrins; Microscopy, Fluorescence; Neoplasms; Photochemotherapy; Porphyrins; Radiation-Sensitizing Agents; Subcellular Fractions; Tumor Cells, Cultured | 2002 |
Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Basal Cell; Floxuridine; Fluorouracil; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Skin Neoplasms; Tumor Cells, Cultured | 2003 |
pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer.
Topics: Breast Neoplasms; Culture Media; Extracellular Space; Hematoporphyrin Photoradiation; Hematoporphyrins; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Porphyrins; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Primary photodamage sites and mitochondrial events after Foscan photosensitization of MCF-7 human breast cancer cells.
Topics: Adenocarcinoma; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Survival; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Female; Golgi Apparatus; Humans; Membrane Potentials; Mesoporphyrins; Mitochondria; Photochemotherapy; Photosensitizing Agents; Time Factors | 2003 |
Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells.
Topics: Breast Neoplasms; Caspases; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Fluorometry; Genes, bcl-2; Heat-Shock Proteins; Humans; Mesoporphyrins; Mitochondria; Molecular Chaperones; Photochemotherapy; Photosensitizing Agents; Proto-Oncogene Proteins c-bcl-2; Subcellular Fractions | 2007 |
[The combined use of photodynamic therapy with ionizing radiation on breast carcinoma cells in vitro].
Topics: Breast Neoplasms; Carcinoma; Combined Modality Therapy; Drug Evaluation, Preclinical; Female; Humans; Indoles; Isoindoles; Laser Therapy; Liposomes; Mesoporphyrins; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured; Zinc Compounds | 1995 |
Assessment of effect of photosensitizers on cytotoxicity of photodynamic therapy in human breast cancer cell cultures.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Mesoporphyrins; Photochemotherapy; Radiation-Sensitizing Agents | 1995 |
In vitro effects and localisation of the photosensitizers m-THPC and m-THPC MD on carcinoma cells of the human breast (MCF-7) and Chinese hamster fibroblasts (V-79).
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Fibroblasts; Humans; Lasers; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured | 1997 |
m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Drug Resistance, Neoplasm; Female; Humans; Mesoporphyrins; Necrosis; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Radiation Tolerance; Radiotherapy; Tumor Cells, Cultured | 1998 |
Photodynamic effects in vitro in fresh gynecologic tumors analyzed with a bioluminescence method.
Topics: Breast Neoplasms; Cell Survival; Female; Humans; In Vitro Techniques; Luminescent Measurements; Mesoporphyrins; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents | 1999 |
Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Intracellular Fluid; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents | 2001 |